Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Massagué J[au]:

Metastatic colonization by circulating tumour cells. Massagué J et al. Nature. (2016)

Understanding the molecular mechanisms driving metastasis. Massagué J et al. Mol Oncol. (2017)

The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells. Wang Q et al. Cell Stem Cell. (2017)

Search results

Items: 1 to 50 of 343

1.

Genome-scale screens identify JNK-JUN signaling as a barrier for pluripotency exit and endoderm differentiation.

Li QV, Dixon G, Verma N, Rosen BP, Gordillo M, Luo R, Xu C, Wang Q, Soh CL, Yang D, Crespo M, Shukla A, Xiang Q, Dündar F, Zumbo P, Witkin M, Koche R, Betel D, Chen S, Massagué J, Garippa R, Evans T, Beer MA, Huangfu D.

Nat Genet. 2019 Jun;51(6):999-1010. doi: 10.1038/s41588-019-0408-9. Epub 2019 May 20.

PMID:
31110351
2.

Transforming Growth Factor-β Signaling in Immunity and Cancer.

Batlle E, Massagué J.

Immunity. 2019 Apr 16;50(4):924-940. doi: 10.1016/j.immuni.2019.03.024. Review.

PMID:
30995507
3.

Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization.

Basnet H, Tian L, Ganesh K, Huang YH, Macalinao DG, Brogi E, Finley LW, Massagué J.

Elife. 2019 Mar 26;8. pii: e43627. doi: 10.7554/eLife.43627.

4.

Author Correction: Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J.

Nat Cell Biol. 2019 Mar;21(3):408. doi: 10.1038/s41556-018-0257-2.

PMID:
30542103
5.

Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J.

Nat Cell Biol. 2018 Aug;20(8):966-978. doi: 10.1038/s41556-018-0138-8. Epub 2018 Jul 23. Erratum in: Nat Cell Biol. 2019 Mar;21(3):408.

6.

Publisher Correction: Contextual determinants of TGFβ action in development, immunity and cancer.

David CJ, Massagué J.

Nat Rev Mol Cell Biol. 2018 Jul;19(7):479. doi: 10.1038/s41580-018-0018-x.

PMID:
29740128
7.

TGF-β Inhibition and Immunotherapy: Checkmate.

Ganesh K, Massagué J.

Immunity. 2018 Apr 17;48(4):626-628. doi: 10.1016/j.immuni.2018.03.037.

8.

Contextual determinants of TGFβ action in development, immunity and cancer.

David CJ, Massagué J.

Nat Rev Mol Cell Biol. 2018 Jul;19(7):419-435. doi: 10.1038/s41580-018-0007-0. Review. Erratum in: Nat Rev Mol Cell Biol. 2018 May 8;:.

PMID:
29643418
9.

Structural basis for genome wide recognition of 5-bp GC motifs by SMAD transcription factors.

Martin-Malpartida P, Batet M, Kaczmarska Z, Freier R, Gomes T, Aragón E, Zou Y, Wang Q, Xi Q, Ruiz L, Vea A, Márquez JA, Massagué J, Macias MJ.

Nat Commun. 2017 Dec 12;8(1):2070. doi: 10.1038/s41467-017-02054-6.

10.

Trends and patterns of air quality in Santa Cruz de Tenerife (Canary Islands) in the period 2011-2015.

Baldasano JM, Massagué J.

Air Qual Atmos Health. 2017;10(8):939-954. doi: 10.1007/s11869-017-0484-x. Epub 2017 May 17.

11.

Corrigendum: Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.

Chen Q, Boire A, Jin X, Valiente M, Emrah Er E, Lopez-Soto A, Jacob LS, Patwa R, Shah H, Xu K, Cross JR, Massagué J.

Nature. 2017 Apr 6;544(7648):124. doi: 10.1038/nature21730. Epub 2017 Mar 29. No abstract available.

PMID:
28355178
12.

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J.

Cell. 2017 Mar 9;168(6):1101-1113.e13. doi: 10.1016/j.cell.2017.02.025.

13.

Understanding the molecular mechanisms driving metastasis.

Massagué J, Batlle E, Gomis RR.

Mol Oncol. 2017 Jan;11(1):3-4. doi: 10.1002/1878-0261.12024. No abstract available.

14.

Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases.

Nayak TR, Andreou C, Oseledchyk A, Marcus WD, Wong HC, Massagué J, Kircher MF.

Nanoscale. 2017 Jan 19;9(3):1110-1119. doi: 10.1039/c6nr08217c.

15.

The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells.

Wang Q, Zou Y, Nowotschin S, Kim SY, Li QV, Soh CL, Su J, Zhang C, Shu W, Xi Q, Huangfu D, Hadjantonakis AK, Massagué J.

Cell Stem Cell. 2017 Jan 5;20(1):70-86. doi: 10.1016/j.stem.2016.10.002. Epub 2016 Nov 23.

16.

Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer.

Chen Q, Boire A, Jin X, Valiente M, Er EE, Lopez-Soto A, Jacob L, Patwa R, Shah H, Xu K, Cross JR, Massagué J.

Nature. 2016 May 26;533(7604):493-498. doi: 10.1038/nature18268. Epub 2016 May 18. Erratum in: Nature. 2017 Apr 6;544(7648):124.

17.

Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massagué J.

Cell. 2016 Mar 24;165(1):45-60. doi: 10.1016/j.cell.2016.02.025.

18.

TGF-β Tumor Suppression through a Lethal EMT.

David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J.

Cell. 2016 Feb 25;164(5):1015-30. doi: 10.1016/j.cell.2016.01.009. Epub 2016 Feb 18.

19.

Arresting supporters: targeting neutrophils in metastasis.

Acharyya S, Massague J.

Cell Res. 2016 Mar;26(3):273-4. doi: 10.1038/cr.2016.17. Epub 2016 Jan 29.

20.

Metastatic colonization by circulating tumour cells.

Massagué J, Obenauf AC.

Nature. 2016 Jan 21;529(7586):298-306. doi: 10.1038/nature17038. Review.

21.

Surviving at a distance: organ specific metastasis.

Obenauf AC, Massagué J.

Trends Cancer. 2015 Sep 1;1(1):76-91.

22.

Surviving at a Distance: Organ-Specific Metastasis.

Obenauf AC, Massagué J.

Trends Cancer. 2015 Sep;1(1):76-91. doi: 10.1016/j.trecan.2015.07.009. Epub 2015 Sep 28. Review.

PMID:
28741564
23.

Metastatic Competence Can Emerge with Selection of Preexisting Oncogenic Alleles without a Need of New Mutations.

Jacob LS, Vanharanta S, Obenauf AC, Pirun M, Viale A, Socci ND, Massagué J.

Cancer Res. 2015 Sep 15;75(18):3713-9. doi: 10.1158/0008-5472.CAN-15-0562. Epub 2015 Jul 24.

24.

Structural determinants of Smad function in TGF-β signaling.

Macias MJ, Martin-Malpartida P, Massagué J.

Trends Biochem Sci. 2015 Jun;40(6):296-308. doi: 10.1016/j.tibs.2015.03.012. Epub 2015 Apr 29. Review.

25.

Therapy-induced tumour secretomes promote resistance and tumour progression.

Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS, Massagué J.

Nature. 2015 Apr 16;520(7547):368-72. doi: 10.1038/nature14336. Epub 2015 Mar 25.

26.

Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.

Sevenich L, Bowman RL, Mason SD, Quail DF, Rapaport F, Elie BT, Brogi E, Brastianos PK, Hahn WC, Holsinger LJ, Massagué J, Leslie CS, Joyce JA.

Nat Cell Biol. 2014 Sep;16(9):876-88. doi: 10.1038/ncb3011. Epub 2014 Aug 3.

27.

Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer.

Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, Darnell RB, Massagué J.

Elife. 2014 Jun 4;3. doi: 10.7554/eLife.02734.

28.

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation.

Morales M, Arenas EJ, Urosevic J, Guiu M, Fernández E, Planet E, Fenwick RB, Fernández-Ruiz S, Salvatella X, Reverter D, Carracedo A, Massagué J, Gomis RR.

EMBO Mol Med. 2014 Jul;6(7):865-81. doi: 10.15252/emmm.201303675.

29.

Immunostaining Protocol: P-Stat3 (Xenograft and Mice).

Calon A, Espinet E, Palomo-Ponce S, Tauriello DVF, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massague J, Sancho E, Batlle E.

Bio Protoc. 2014 May 5;4(9). pii: e1120. doi: 10.21769/BioProtoc.1120.

30.

Metastatic stem cells: sources, niches, and vital pathways.

Oskarsson T, Batlle E, Massagué J.

Cell Stem Cell. 2014 Mar 6;14(3):306-21. doi: 10.1016/j.stem.2014.02.002. Review.

31.

Serpins promote cancer cell survival and vascular co-option in brain metastasis.

Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, Chaft JE, Kris MG, Huse JT, Brogi E, Massagué J.

Cell. 2014 Feb 27;156(5):1002-16. doi: 10.1016/j.cell.2014.01.040.

32.

TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.

Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massagué J, Benezra R.

Cell Rep. 2013 Dec 12;5(5):1228-42. doi: 10.1016/j.celrep.2013.11.014.

33.

Origins of metastatic traits.

Vanharanta S, Massagué J.

Cancer Cell. 2013 Oct 14;24(4):410-21. doi: 10.1016/j.ccr.2013.09.007. Review.

34.

Hypoxia signaling--license to metastasize.

Vanharanta S, Massagué J.

Cancer Discov. 2013 Oct;3(10):1103-4. doi: 10.1158/2159-8290.CD-13-0481.

35.

Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma.

Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J.

Cell. 2013 Aug 29;154(5):1060-1073. doi: 10.1016/j.cell.2013.07.036.

36.

Signalling change: signal transduction through the decades.

Hynes NE, Ingham PW, Lim WA, Marshall CJ, Massagué J, Pawson T.

Nat Rev Mol Cell Biol. 2013 Jun;14(6):393-8. doi: 10.1038/nrm3581. Epub 2013 May 2. Review.

PMID:
23636498
37.

Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer.

Vanharanta S, Shu W, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massagué J.

Nat Med. 2013 Jan;19(1):50-6. doi: 10.1038/nm.3029. Epub 2012 Dec 9.

38.

Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.

Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Céspedes MV, Sevillano M, Nadal C, Jung P, Zhang XH, Byrom D, Riera A, Rossell D, Mangues R, Massagué J, Sancho E, Batlle E.

Cancer Cell. 2012 Nov 13;22(5):571-84. doi: 10.1016/j.ccr.2012.08.013.

39.

TGFβ signalling in context.

Massagué J.

Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30. doi: 10.1038/nrm3434. Epub 2012 Sep 20. Review.

40.

Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways.

Aragón E, Goerner N, Xi Q, Gomes T, Gao S, Massagué J, Macias MJ.

Structure. 2012 Oct 10;20(10):1726-36. doi: 10.1016/j.str.2012.07.014. Epub 2012 Aug 23.

41.

Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.

Chen Q, Massagué J.

Clin Cancer Res. 2012 Oct 15;18(20):5520-5. doi: 10.1158/1078-0432.CCR-11-2904. Epub 2012 Aug 9.

42.

A CXCL1 paracrine network links cancer chemoresistance and metastasis.

Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E, Massagué J.

Cell. 2012 Jul 6;150(1):165-78. doi: 10.1016/j.cell.2012.04.042.

43.

Ubiquitin removal in the TGF-β pathway.

Aggarwal K, Massagué J.

Nat Cell Biol. 2012 Jun 29;14(7):656-7. doi: 10.1038/ncb2534.

PMID:
22743709
44.

TGF-β control of stem cell differentiation genes.

Massagué J, Xi Q.

FEBS Lett. 2012 Jul 4;586(14):1953-8. doi: 10.1016/j.febslet.2012.03.023. Epub 2012 Apr 10. Review.

45.

Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer.

Huang J, Li YM, Massague J, Sicheneder A, Vallera DA, Hall WA.

J Neurooncol. 2012 Sep;109(2):229-38. doi: 10.1007/s11060-012-0904-6. Epub 2012 Jun 14.

PMID:
22696210
46.

Field cancerization: something new under the sun.

Vanharanta S, Massagué J.

Cell. 2012 Jun 8;149(6):1179-81. doi: 10.1016/j.cell.2012.05.013.

47.

TGF-β signaling in development and disease.

Massagué J.

FEBS Lett. 2012 Jul 4;586(14):1833. doi: 10.1016/j.febslet.2012.05.030. Epub 2012 May 28. No abstract available.

48.

A poised chromatin platform for TGF-β access to master regulators.

Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V, Studer L, Mark W, Patel DJ, Massagué J.

Cell. 2011 Dec 23;147(7):1511-24. doi: 10.1016/j.cell.2011.11.032.

49.

Extracellular matrix players in metastatic niches.

Oskarsson T, Massagué J.

EMBO J. 2012 Jan 18;31(2):254-6. doi: 10.1038/emboj.2011.469. Epub 2011 Dec 16. No abstract available.

50.

VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, Yan J, Hua Y, Tiede BJ, Lu X, Haffty BG, Pantel K, Massagué J, Kang Y.

Cancer Cell. 2011 Dec 13;20(6):701-14. doi: 10.1016/j.ccr.2011.11.002. Epub 2011 Dec 1.

Supplemental Content

Loading ...
Support Center